Travere Therapeutics, Inc. (TVTX)
USD 16.86
(-1.63%)
USD 16.86
(-1.63%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -280.02 Million | -186.29 Million | -14.79 Million | -42.74 Million | -58.21 Million | -24.95 Million |
| Net Income | -376.33 Million | -278.48 Million | -180.09 Million | -169.43 Million | -146.42 Million | -102.67 Million |
| Depreciation & Amortization | 44.93 Million | 33.07 Million | 26.61 Million | 24.57 Million | 20.4 Million | 18.66 Million |
| Deferred income taxes | -388.65 Million | - | 4.11 Million | 1.99 Million | 41.29 Million | 20.34 Million |
| Stock-based compensation | 44.24 Million | 38.14 Million | 29.56 Million | 23.61 Million | 21.1 Million | 19.77 Million |
| Change in working capital | -25.47 Million | 904 Thousand | 79.97 Million | -26.04 Million | 2.68 Million | 11.06 Million |
| Other non-cash items | 421.26 Million | 19.03 Million | 23.81 Million | 102.54 Million | 2.72 Million | 7.86 Million |
| Investing Cash Flow | 55.77 Million | -32.55 Million | -137.62 Million | -61.32 Million | 19.86 Million | -203.29 Million |
| Investments in PPE | -42.25 Million | -28.55 Million | -24.15 Million | -119.84 Million | -15.56 Million | -19.7 Million |
| Acquisitions | 109.36 Million | - | 19.05 Million | 113.07 Million | 15.37 Million | -15 Million |
| Investment purchases | -443.94 Million | -385.38 Million | -547.07 Million | -214.96 Million | -223.71 Million | -331.34 Million |
| Sales/Maturities of investments | 334.57 Million | 381.99 Million | 433.6 Million | 273.48 Million | 259.14 Million | 162.75 Million |
| Other Investing Activities | 98.03 Million | -600 Thousand | -19.05 Million | -113.07 Million | -15.37 Million | -202.56 Million |
| Financing Cash Flow | 218.75 Million | 117.57 Million | 231.68 Million | 127.71 Million | -2.07 Million | 231.86 Million |
| Debt repayment | - | -104.92 Million | - | - | - | -40.2 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | 2.11 Million | 2.04 Million | - | - |
| Common Stock Issuance | 222.23 Million | 27.1 Million | 239.88 Million | 137.46 Million | 1.61 Million | 15.89 Million |
| Other Financing Activities | 218.75 Million | 12.64 Million | 231.68 Million | 127.71 Million | -3.69 Million | 272.06 Million |
| Accounts receivables | -11.26 Million | -682 Thousand | -59 Thousand | 2.3 Million | -5.18 Million | 152 Thousand |
| Accounts payables | 24.76 Million | 2.3 Million | 2.77 Million | -6.03 Million | 9.25 Million | -2.7 Million |
| Inventory | -39.42 Million | -2.06 Million | -1.81 Million | -5.06 Million | -1.95 Million | -2.77 Million |
| Other working capital | 446 Thousand | 1.34 Million | 79.08 Million | -17.24 Million | 567 Thousand | 16.39 Million |
| Cash at beginning of period | 61.68 Million | 165.75 Million | 84.77 Million | 62.43 Million | 102.87 Million | 99.39 Million |
| Cash at end of period | 58.17 Million | 61.68 Million | 165.75 Million | 84.77 Million | 62.43 Million | 102.87 Million |
| Capital Expenditure | -42.25 Million | -28.55 Million | -24.15 Million | -119.84 Million | -15.56 Million | -19.7 Million |
| Effect of forex changes on cash | 1.98 Million | -2.79 Million | 1.71 Million | -1.3 Million | -9000.00 | -135 Thousand |
| Net cash flow / Change in cash | -3.51 Million | -104.06 Million | 80.98 Million | 22.33 Million | -40.43 Million | 3.47 Million |
| Free Cash Flow | -322.28 Million | -214.84 Million | -38.94 Million | -162.58 Million | -73.77 Million | -44.65 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -55.56 Million | -69.65 Million | -136.06 Million | -376.33 Million | -88.59 Million | -115.77 Million |
| Depreciation & Amortization | 11.23 Million | 10.34 Million | 9.88 Million | 44.93 Million | 11.85 Million | 5.59 Million |
| Deferred income taxes | - | - | - | -388.65 Million | -109.42 Million | 49.58 Million |
| Stock-based compensation | 8.02 Million | 9.91 Million | 9.75 Million | 44.24 Million | 8.14 Million | 10.73 Million |
| Change in working capital | 63.68 Million | -60.73 Million | -2.94 Million | -25.47 Million | 7.1 Million | -3.56 Million |
| Other non-cash items | -69.52 Million | 94.44 Million | 364 Thousand | 421.26 Million | 100.44 Million | -5.7 Million |
| Investing Cash Flow | 46.12 Million | 28.61 Million | 104.89 Million | 55.77 Million | -16.95 Million | 133.31 Million |
| Investments in PPE | 18.37 Million | -11.99 Million | -6.46 Million | -42.25 Million | -5.53 Million | -5.55 Million |
| Acquisitions | - | - | - | 109.36 Million | 12.64 Million | 5.55 Million |
| Investment purchases | - | - | - | -443.94 Million | -62.64 Million | -155.63 Million |
| Sales/Maturities of investments | 54.31 Million | 105.6 Million | 111.36 Million | 334.57 Million | 50 Million | 87.7 Million |
| Other Investing Activities | -26.56 Million | -65 Million | -6.46 Million | 98.03 Million | -11.42 Million | 201.24 Million |
| Financing Cash Flow | 46 Thousand | 782 Thousand | -525 Thousand | 218.75 Million | 124 Thousand | -634 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -1.3 Million | 1.3 Million | - | 222.23 Million | 908 Thousand | 151 Thousand |
| Other Financing Activities | 1.35 Million | -525 Thousand | -525 Thousand | 218.75 Million | 124 Thousand | -634 Thousand |
| Accounts receivables | -731 Thousand | -1.73 Million | -1.54 Million | -11.26 Million | -7.96 Million | 440 Thousand |
| Accounts payables | -2.93 Million | 9.2 Million | -24.84 Million | 24.76 Million | 17.29 Million | 4.95 Million |
| Inventory | -246 Thousand | -1.41 Million | -1.82 Million | -39.42 Million | -22.39 Million | -4 Million |
| Other working capital | 68.3 Million | -66.78 Million | -1.52 Million | 446 Thousand | 20.16 Million | -4.95 Million |
| Cash at beginning of period | 32.29 Million | 43.25 Million | 58.17 Million | 61.68 Million | 144.24 Million | 70.87 Million |
| Cash at end of period | 36.4 Million | 32.29 Million | 43.25 Million | 58.17 Million | 58.17 Million | 144.24 Million |
| Capital Expenditure | 18.37 Million | -11.99 Million | -6.46 Million | -42.25 Million | -5.53 Million | -5.55 Million |
| Effect of forex changes on cash | 453 Thousand | -109 Thousand | -293 Thousand | 1.98 Million | 1.23 Million | -180 Thousand |
| Net cash flow / Change in cash | 4.11 Million | -10.96 Million | -14.92 Million | -3.51 Million | -86.06 Million | 73.37 Million |
| Free Cash Flow | -23.76 Million | -52.23 Million | -125.47 Million | -322.28 Million | -76 Million | -64.69 Million |
ASRT
600988
BHARATWIRE
BBBMF
DCON
301165